IperionX
- Market cap
- 562.92M
- P/E (TTM)i
- -7.77
- P/Bi
- 6.37
- EPSi
- -2.00
- Div yieldi
- 0.00%
- 52W posi
- 0%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- Total institutional ownership rose 11.2 percentage points.
Institutional ownership
- Held by institutions
- 86.82% +11.17pp
- Institutions
- 100
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-07-09
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Todd Hannigan | Executive Chairperson | 7.49% |
| Anastasios Arima | Founder, MD, CEO & Executive Director | 3.47% |
| Toby Symonds | President & Chief Strategy Officer | 0.97% |
| Lorraine Martin | Independent Non-Executive Director | 0.35% |
| Vaughn Taylor | Independent Non-Executive Director | 0.27% |
| Beverly Wyse | Independent Non-Executive Director | 0.21% |
| Melissa Waller | Independent Non-Executive Director | 0.13% |
| Marcela Rocha De Castro | Chief Accounting Officer | 0.11% |
| R. Tripeny | Independent Non-Executive Director | 0.03% |
| Michael Loparco | Independent Non-Executive Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-02 | Michael Loparco | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-14 | Beverly Wyse | Independent Non-Executive Director | Derivative Exercise and Retained | +106,093 | $0.87 |
| 2026-07-13 | R. Tripeny | Independent Non-Executive Director | Open Market Acquisition | +3,846 | $26.00 |
| 2026-07-12 | Todd Hannigan | Executive Chairperson | Open Market Acquisition | +525,000 | $3.58–3.59 |
| 2026-07-09 | Lorraine Martin | Independent Non-Executive Director | Open Market Acquisition | +4,100 | $24.51 |
| 2026-07-09 | Anastasios Arima | Founder, MD, CEO & Executive Director | Open Market Acquisition | +138,720 | $3.58 |
| 2026-07-09 | Toby Symonds | President & Chief Strategy Officer | Open Market Acquisition | +2,040 | $24.55 |
| 2026-04-28 | Todd Hannigan | Executive Chairperson | Open Market Acquisition | +480,000 | $4.20–4.48 |
| 2026-04-27 | Anastasios Arima | Founder, MD, CEO & Executive Director | Open Market Acquisition | +110,000 | $4.49 |
| 2026-04-01 | Anastasios Arima | Founder, MD, CEO & Executive Director | Other Derivative Acquisition | +237,944 | $18.00 |
| 2026-04-01 | Anastasios Arima | Founder, MD, CEO & Executive Director | Other Derivative Acquisition | +564,759 | $18.00 |
| 2026-04-01 | Anastasios Arima | Founder, MD, CEO & Executive Director | Other Derivative Acquisition | +639,205 | $22.00 |
| 2026-04-01 | Todd Hannigan | Executive Chairperson | Other Derivative Acquisition | +196,086 | $18.00 |
| 2026-04-01 | Todd Hannigan | Executive Chairperson | Other Derivative Acquisition | +465,410 | $18.00 |
| 2026-04-01 | Todd Hannigan | Executive Chairperson | Other Derivative Acquisition | +526,760 | $22.00 |
| 2026-04-01 | Toby Symonds | President & Chief Strategy Officer | Other Derivative Acquisition | +226,047 | $18.00 |
| 2026-04-01 | Toby Symonds | President & Chief Strategy Officer | Other Derivative Acquisition | +536,521 | $18.00 |
| 2026-04-01 | Toby Symonds | President & Chief Strategy Officer | Other Derivative Acquisition | +607,244 | $22.00 |
| 2026-04-01 | Marcela Rocha De Castro | Chief Accounting Officer | Other Derivative Acquisition | +127,993 | $11.00 |
| 2026-03-26 | R. Tripeny | Independent Non-Executive Director | Open Market Acquisition | +4,187 | $23.76 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:20:56 · For reference only, not investment advice and not tailored to your situation.